People with MS, a chronic inflammatory disease of the central nervous system, experience a wide range of life-limiting symptoms, ranging from problems with vision, movement and sensation to fatigue, pain and issues with memory and thinking. Perhaps worse still is the unpredictability of when these symptoms might get worse. Addressing the biggest challenges for people living with MS means relentless discovery, development and delivery of transformative solutions with the goal of achieving complete disease control.
The development and subsequent physical and mental decline in people with neurodegenerative conditions such as Parkinson’s disease, amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease have a devastating impact on the lives of those affected and their families. Pursuing innovation is critical to changing the course of these diseases and supporting those living with them and their caregivers.
SMA is a rare, devastating genetic disease that leads to progressive muscle weakness, paralysis, and, when left untreated in its most severe forms, permanent ventilation or death in 90% of children by age 2. It is a leading genetic cause of infant death. All those diagnosed with SMA should be able to benefit from cutting-edge technology, through turning promising transformative medicines into proven treatments.
Sandoz receives FDA approval for Tyruko® (natalizumab-sztn), first and only FDA-approved biosimilar for relapsing forms of multiple sclerosis
Novartis builds on neuroscience pipeline and xRNA platform capabilities with acquisition of DTx Pharma
Novartis publishes new five-year efficacy data on Kesimpta® (ofatumumab) for the treatment of relapsing multiple sclerosis
My Love Stories
Finding yourself. Pursuing a hobby. Becoming a parent. In a world of unique love stories, Kelly-Ann, Trish, and Elisabeth embarked on a remarkable journey filled with twists and turns, all while navigating the complexities of a multiple sclerosis (MS) diagnosis. Though their path was challenging, they never gave up.
Fighting MS through innovation
Investing in innovative treatments is vital to alleviate the suffering caused by multiple sclerosis (MS).
MS Shared decision making tools
Are you interested in having more collaborative discussions with your healthcare team about your multiple sclerosis (MS) management? Do you feel confident discussing your MS management with your healthcare practitioner?
Events and scientific meetings
|ACTRIMS||Americas Committee for Treatment and Research in Multiple Sclerosis||https://www.actrims.org/|
|AAN||American Academy of Neurology||https://www.aan.com/|
|EAN||European Academy of Neurology||https://www.ean.org/|
|ECTRIMS||European Committee for Treatment and Research in Multiple Sclerosis||https://ectrims.eu/|
Other therapeutic areas
Cardiovascular, renal and metabolic
Transforming how the world tackles cardiovascular disease and delivering new treatments for people with chronic kidney diseases
Working to create a world where the millions of people with immunological conditions, and those who treat them, can live without compromise.
Combining the power of science and empathy to unravel the inner workings of cancer and develop innovative therapies that restore hope to those with cancer and their loved ones.